NCT06021873

Brief Summary

Treating patients with super-obesity has always been challenging for bariatric surgeons due to the higher risk of postoperative complications and the limited success of commonly used bariatric procedures (restrictive and hypo-absorptive). In this context, these patients are often considered for more complex procedures, such as hypo-absorptive interventions. Over the past 15 years, a new hypo-absorptive procedure called single-anastomosis duodenal switch with biliopancreatic diversion (SADI-S) has been introduced and recognized as a bariatric procedure by leading national and international scientific societies. It has shown promising short- and medium-term results regarding weight loss and metabolic improvements. The SADI-S procedure is a technically complex multi-quadrant surgery. This study aims to evaluate the equivalence in terms of morbidity between laparoscopic and robotic approaches for patients undergoing this procedure.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for not_applicable

Timeline
31mo left

Started Jan 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Jan 2024Dec 2028

First Submitted

Initial submission to the registry

July 10, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 1, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2028

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

September 1, 2023

Status Verified

May 1, 2023

Enrollment Period

4.6 years

First QC Date

July 10, 2023

Last Update Submit

August 28, 2023

Conditions

Keywords

minimally-invasive surgeryrobotic surgerysingle anastomosis duodeno-ileal bypass with sleeve gastrectomy (sadi-s)

Outcome Measures

Primary Outcomes (1)

  • Evaluation of post-operative complications

    Comparison between the laparoscopic and robotic approach to Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy in order to evaluate the post-operative complications rate within 30 days from the surgical procedure. Complications will be expressed in absolute numbers and divided into major complications (grade III-IV) and minor complications (grade I-II) according to the Clavien-Dindo classification.

    30 days

Secondary Outcomes (1)

  • Evaluation of morbidity, mortality and cost-analysis

    30 days

Study Arms (2)

Laparoscopic SADI-S

ACTIVE COMPARATOR

Patients with indication to laparoscopic Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy

Procedure: SADI-S

Robotic SADI-S

ACTIVE COMPARATOR

Patients with indication to robotic Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy

Procedure: SADI-S

Interventions

SADI-SPROCEDURE

Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy

Laparoscopic SADI-SRobotic SADI-S

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Patients eligible for Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy using a minimally invasive technique
  • Informed consent

You may not qualify if:

  • Patients eligible for different bariatric procedures than SADI-S

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rome, 00168, Italy

Location

MeSH Terms

Conditions

Obesity, Morbid

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Marco Raffaelli, Prof

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Monocentric, interventional, prospective, randomized 1:1, with comparison of two surgical approaches
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2023

First Posted

September 1, 2023

Study Start

January 1, 2024

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

September 1, 2023

Record last verified: 2023-05

Locations